Highly Commended in the Oncology category of the British Medical Association Book Awards 2016. Written by internationally recognised key opinion leaders in all of the oncology sub-disciplines and covering all aspects of the field, the Oxford Textbook of Oncology, Third Edition reflects current best practice and represents a modern approach to managing the cancer patient. This is a definitive resource for oncologists of all varieties.

Zusatztext Each chapter is nicely illustrated with schemes, cartoons and images. The text, although written by top oncologists, is readily understandable for a non-expert. Thus, the textbook will no doubt be appreciated by a broader audience. Informationen zum Autor David Kerr has made a sustained and internationally recognised contribution to cancer care and research in the field of medical oncology over the past three decades. He has published over 400 papers in high profile journals, authored over twenty books and has been awarded four prestigious, international research prizes, including the NHS's first Nye Bevan award for Innovation. His scientific standing has been recognised by election as Fellow of the Royal College of Physicians, Fellow of Academy of Medical Sciences, President of the European society of Medical Oncology (2009-2011) and Founding Fellow of the European Academy of Cancer Sciences. Klappentext Written by internationally recognised key opinion leaders in all of the oncology sub-disciplines and covering all aspects of the field, the Oxford Textbook of Oncology , Third Edition reflects current best practice and represents a modern approach to managing the cancer patient. This is a definitive resource for oncologists of all varieties. Zusammenfassung Written by internationally recognised key opinion leaders in all of the oncology sub-disciplines and covering all aspects of the field, the Oxford Textbook of Oncology, Third Edition reflects current best practice and represents a modern approach to managing the cancer patient. This is a definitive resource for oncologists of all varieties. Inhaltsverzeichnis Section 1: Hallmarks of Cancer 1: Douglas Hanahan and Robert A. Weinberg: The hallmarks of cancer 2: Shujuan Liu and Ahmed Ashour Ahmed: Growth factors and uncontrolled proliferation 3: Stefan Knapp: Cell signalling pathways 4: Simon Carr and Nicholas La Thangue: Cell cycle control 5: Amanda S. Coutts, Sandra Maniam, and Nicholas La Thangue: Cancer cell death 6: Yull E. Arriaga and Arthur E. Frankel: Angiogenesis 7: Andrew P. Mazar, Andrey Ugolkov, Jack Henkin, Richard Ahn, and Thomas V. O'Halloran: Invasion and metastases 8: Sir Walter Bodmer and Jenny Wilding: Genetic instability 9: E. Dikomey, K. Borgmann, M. Kriegs, W. Mansour, C. Petersen, and T. Rieckmann: DNA repair after oncological therapy 10: Andreas Trumpp: Biology of cancer stem cells 11: Richard D Kennedy, Manuel Salto-Tellez, D. Paul Harkin, and Patrick G Johnston: Biomarker identification and clinical validation 12: Campbell SD Roxburgh and Donald C McMillan: Cancer, immunity, and inflammation 13: Cameron Snell, Kevin C Gatter, Adrian L Harris, Francesco Pezzella: Cancer and metabolism Section 2: Etiology and Epidemiology of Cancer 14: Jonathan Samet: Smoking and cancer 15: Chris Boshoff: Viruses 16: Paula A. Oliveira: Chemical carcinogens 17: Klaus Trott: Radiation 18: Ellen Kampman and Franzel van Duijnhoven: Body fatness, physical activity, diet, and other lifestyle factors Section 3: Principles of Oncology 19: PG Boelens, CBM van den Broek, and CJH van de Velde: Practice points for surgical oncology 20: Annekatrin Singer, Stephanie E. Combs, Jürgen Debus, and Michael Baumann: Practice points for radiation oncology 21: David Kerr, Daniel Haller, and Jaap Verweij: Principles of chemotherapy 22: David N Church, Rachel S Midgley, and David J Kerr: Delivery of multidisciplinary cancer care 23: Michael Ong and Udai Banerji: Principles of clinical pharmacology: Introduction to pharmacokinetics and pharmacodynamics 24: Dan Sargeant and Qian Shi: Design and analysis of clinical trials 25: Eric A. Singer: Medical ethics in oncology 26: Jeffrey Peppercorn: Health economic assessment of cancer therapy Section 4: Population Health 27: Masoud Samiei: Cancer control: The role of n...

Vorwort
Highly Commended in the Oncology category of the British Medical Association Book Awards 2016.

Autorentext
David Kerr has made a sustained and internationally recognised contribution to cancer care and research in the field of medical oncology over the past three decades. He has published over 400 papers in high profile journals, authored over twenty books and has been awarded four prestigious, international research prizes, including the NHS's first Nye Bevan award for Innovation. His scientific standing has been recognised by election as Fellow of the Royal College of Physicians, Fellow of Academy of Medical Sciences, President of the European society of Medical Oncology (2009-2011) and Founding Fellow of the European Academy of Cancer Sciences.

Klappentext

Written by internationally recognised key opinion leaders in all of the oncology sub-disciplines and covering all aspects of the field, the Oxford Textbook of Oncology, Third Edition reflects current best practice and represents a modern approach to managing the cancer patient. This is a definitive resource for oncologists of all varieties.

Inhalt

• Section 1: Hallmarks of Cancer

• 1: Douglas Hanahan and Robert A. Weinberg: The hallmarks of cancer

• 2: Shujuan Liu and Ahmed Ashour Ahmed: Growth factors and uncontrolled proliferation

• 3: Stefan Knapp: Cell signalling pathways

• 4: Simon Carr and Nicholas La Thangue: Cell cycle control

• 5: Amanda S. Coutts, Sandra Maniam, and Nicholas La Thangue: Cancer cell death

• 6: Yull E. Arriaga and Arthur E. Frankel: Angiogenesis

• 7: Andrew P. Mazar, Andrey Ugolkov, Jack Henkin, Richard Ahn, and Thomas V. O'Halloran: Invasion and metastases

• 8: Sir Walter Bodmer and Jenny Wilding: Genetic instability

• 9: E. Dikomey, K. Borgmann, M. Kriegs, W. Mansour, C. Petersen, and T. Rieckmann: DNA repair after oncological therapy

• 10: Andreas Trumpp: Biology of cancer stem cells

• 11: Richard D Kennedy, Manuel Salto-Tellez, D. Paul Harkin, and Patrick G Johnston: Biomarker identification and clinical validation

• 12: Campbell SD Roxburgh and Donald C McMillan: Cancer, immunity, and inflammation

• 13: Cameron Snell, Kevin C Gatter, Adrian L Harris, Francesco Pezzella: Cancer and metabolism

• Section 2: Etiology and Epidemiology of Cancer

• 14: Jonathan Samet: Smoking and cancer

• 15: Chris Boshoff: Viruses

• 16: Paula A. Oliveira: Chemical carcinogens

• 17: Klaus Trott: Radiation

• 18: Ellen Kampman and Franzel van Duijnhoven: Body fatness, physical activity, diet, and other lifestyle factors

• Section 3: Principles of Oncology

• 19: PG Boelens, CBM van den Broek, and CJH van de Velde: Practice points for surgical oncology

• 20: Annekatrin Singer, Stephanie E. Combs, Jürgen Debus, and Michael Baumann: Practice points for radiation oncology

• 21: David Kerr, Daniel Haller, and Jaap Verweij: Principles of chemotherapy

• 22: David N Church, Rachel S Midgley, and David J Kerr: Delivery of multidisciplinary cancer care

• 23: Michael Ong and Udai Banerji: Principles of clinical pharmacology: Introduction to pharmacokinetics and pharmacodynamics

• 24: Dan Sargeant and Qian Shi: Design and analysis of clinical trials

• 25: Eric A. Singer: Medical ethics in oncology

• 26: Jeffrey Peppercorn: Health economic assessment of cancer therapy

• Section 4: Population Health

• 27: Masoud Samiei: Cancer control: The role of national plans

• 28: Sarah Goltz and Julian Lob-Levyt: Cancer prevention: Vaccination

• 29: Hans-Joerg Senn, Nadir Arber, and Dirk Schr…